FDA Alerts Patients and Health Care Professionals of EpiPen Auto-Injector Errors Related to Device Malfunctions and User
** FAACT is sharing this press release from the U.S. Food and Drug Administration (FDA) March 24, 2020: FDA is alerting patients, caregivers and health care professionals that EpiPen 0.3mg and EpiPen Jr 0.15mg
by Stacey Stratton The holidays are approaching and can bring your family party invites and travel plans. Here are some food allergy safety reminders to help you have a safe and enjoyable holiday season. 1.
FAACT CEO, Eleanor Garrow-Holding, just attended the annual meeting of the American College of Allergy, Asthma, and Immunology – one of the nation’s leading associations for medical care professionals working on